Saskatchewan Mental Hospital in Weyburn was the principal setting for Humphry Osmond and Abram Hoffer’s early investigations of LSD in Canada and a formative site in the history of psychedelic therapy. Their work began within a model that treated the drug as a means of inducing temporary madness, but the reports gathered from patients increasingly suggested experiences of insight, connection, and transcendence. At Weyburn, the clinical question therefore widened: the treatment might depend not just on the substance, but on what people experienced and on the circumstances in which they experienced it.

A new center for research

Osmond turned to Saskatchewan after the authorities at St. George’s Hospital proved unsupportive of his research on mescaline. The western Canadian province offered a striking contrast. Beginning in the mid-1940s, its leftist government had introduced major public-policy reforms, including Canada’s first publicly funded health-care system, and sought to make the province a center of advanced medical research. Generous funding and unusual freedom were intended to attract researchers to the prairie region. After answering an advertisement in The Lancet, Osmond was invited to move his family and research project to Weyburn, a remote agrarian community forty-five miles north of the North Dakota border.

The hospital there soon became the world’s most important hub of psychedelic research, although researchers at the time understood the compounds through the category of psychotomimetics: drugs thought to produce states resembling psychosis. Osmond and his new colleague Abram Hoffer, a Canadian psychiatrist who served as research director, began experiments using LSD-25 supplied by Sandoz. The institution’s importance lay not only in the experiments themselves, but in the way their results would unsettle the framework that had first made those experiments seem plausible.

Testing the delirium model

The researchers’ most consequential proposal was to use a single, high-dose LSD session to induce a temporary delirium resembling delirium tremens, the severe condition associated with alcohol withdrawal. They hypothesized that an alcoholic’s encounter with this frightening state might shock the person into sobriety. Over the next decade, Osmond and Hoffer tested the approach on more than seven hundred alcoholics. They reported that roughly half of the volunteers got sober and remained so for at least several months, and regarded the results as better than those of other available therapies.

The treatment also led them to give unusual weight to the subjects’ accounts of their own experience. Hoffer later described the experience, rather than the chemical alone, as a key factor in therapy. This emphasis marked a break with behaviorist approaches that treated observable behavior as the proper object of study and subjective experience as irrelevant. In the hospital’s work, the question of whether patients improved could not be separated from what they said had happened to them during their sessions.

Those reports complicated the original delirium hypothesis. Psychotic changes such as hallucinations, paranoia, and anxiety did occur, but many patients described experiences that did not resemble delirium tremens or madness. Some reported feeling united with the world, seeing themselves objectively, or experiencing heightened sensation and new understanding. Osmond and Hoffer came to consider whether apparent signs of psychosis might instead be interpreted as mystical union, visionary experience, or ecstasy. The contrast between their starting theory and their patients’ reports made Weyburn a site where the meaning of the drug itself was being reconsidered.

Experience, care, and the treatment setting

The hospital’s clinical work also suggested that the surroundings and human relationships within a session mattered. Osmond and Hoffer learned from volunteers that the environment could influence the kind of experience a person had. They suspected that an engaged, empathetic therapist—ideally one who had experienced LSD personally—could help prevent a bad session. They also wondered whether some of the psychotic reactions they observed arose partly from an impersonal clinical atmosphere, represented by the metaphor of a white room and a white-coated clinician.

The language of set and setting would become more closely associated with Timothy Leary’s work at Harvard about a decade later, but Osmond and Hoffer were already recognizing the importance of those conditions at Weyburn. Their observations supplied a practical qualification to the simple idea that a drug’s effect could be understood from its chemistry alone. The room, the therapist, and the patient’s experience belonged to the treatment, even when researchers hoped to isolate the drug’s effects.

Weyburn was also connected to a wider North American research network. By the late 1950s, Al Hubbard visited to assist Osmond and Hoffer with their work on alcoholism, bringing therapeutic advice and LSD supplies as he traveled among research groups. His visits placed the hospital within an emerging circuit through which people, clinical methods, and drugs moved between distant centers. This wider exchange did not erase the particular importance of Weyburn: the Saskatchewan trials had helped make LSD treatment for alcoholism internationally visible.

Replication and legacy

By the end of the decade, LSD was widely regarded in North America as a promising treatment for alcohol addiction. On the strength of the Saskatchewan results, the provincial government helped make LSD therapy a standard treatment option for alcoholics in the province. Yet the findings drew skepticism from other parts of the Canadian medical establishment, where their apparent success seemed difficult to credit. In the early 1960s, the Addiction Research Foundation in Toronto attempted to replicate the trials under tighter controls.

The replication changed more than the measurement of outcomes. To isolate the drug from other variables, clinicians placed alcoholic volunteers in neutral rooms and were instructed not to engage with them during their trips except to administer an extensive questionnaire. Some volunteers were restrained or blindfolded, or both. The results did not match those reported from Saskatchewan, and several participants endured terrifying experiences. Critics concluded that LSD treatment was less effective under rigorous experimental conditions; its supporters argued that the replication had stripped away conditions essential to the therapy’s success. Both conclusions captured part of the dispute, but the contrast made clear that the treatment’s clinical setting could not be treated as incidental.

The hospital’s lasting significance rests in this double legacy. Its research helped establish LSD as a proposed treatment for alcoholism, while the mismatch between the psychotomimetic theory and the positive, often transformative experiences described by patients challenged researchers to attend to subjective experience. The later replication controversy sharpened the question of what counted as a fair test: whether treatment could be evaluated apart from the therapeutic relationship and the conditions that shaped a session. Weyburn thus stands not simply as the address of early experiments, but as a place where the promise of psychedelic therapy and the difficulty of measuring it became inseparable.